Ciclopirox: Broad-Spectrum Antifungal for Nail and Skin Infections
Ciclopirox is a synthetic broad-spectrum antifungal agent belonging to the hydroxypyridone class, chemically distinct from azoles, allylamines, and polyenes. Its unique mechanism of action via metal chelation rather than ergosterol pathway inhibition confers activity against a wide range of dermatophytes, yeasts, and moulds, as well as some gram-positive and gram-negative bacteria.
Ciclopirox is primarily used in topical formulations for superficial fungal infections of the skin and nails. The nail lacquer formulation at 8 percent concentration enables drug penetration through the nail plate to reach the nail bed, making it one of the few non-systemic options for onychomycosis. Treatment requires patience as nail regrowth takes many months.
Mechanism of Action
Ciclopirox chelates trivalent metal cations, particularly iron(III) and aluminium(III), which are essential cofactors for metalloenzymes within fungal cells. By depleting available intracellular iron, ciclopirox inhibits iron-dependent enzymes involved in the electron transport chain, DNA synthesis, and cell wall synthesis. This multitarget mechanism reduces the likelihood of single-point resistance mutations developing, distinguishing ciclopirox from azoles which target a single enzyme (lanosterol 14-alpha-demethylase). The drug is fungicidal at higher concentrations and fungistatic at lower concentrations, and it also has anti-inflammatory properties relevant to seborrhoeic dermatitis treatment.
Indications
Topical ciclopirox cream and gel are used for dermatophytosis of the skin (tinea pedis, tinea corporis, tinea cruris), cutaneous candidosis, and pityriasis versicolor. The 1 percent shampoo is approved for seborrhoeic dermatitis of the scalp. The 8 percent nail lacquer (ciclopirox olamine) is the primary application for mild to moderate onychomycosis of the toenails and fingernails without matrix involvement. Ciclopirox nail lacquer is an alternative for patients in whom systemic antifungals are contraindicated due to drug interactions or hepatic concerns.
Dosage and Administration
For skin infections, ciclopirox cream or gel is applied once or twice daily to affected areas and surrounding skin, typically for two to four weeks. For onychomycosis, the 8 percent lacquer is applied to the affected nail(s) and surrounding nail folds once daily in the evening. Before each new application, the lacquer layer from the previous application should be removed with alcohol; the nail should be filed regularly by a healthcare professional to reduce thickness. Treatment duration for toenail onychomycosis is typically six months, for fingernails three to six months. Cure rates with monotherapy lacquer are moderate and lower than systemic options.
Side Effects
Local reactions at the application site are the most common adverse effects and include erythema, itching, burning, and skin irritation. These reactions are generally mild and transient. Contact dermatitis or allergic reactions to ciclopirox or formulation excipients occur rarely. For the nail lacquer, periungual erythema and nail discolouration have been reported. Systemic absorption through intact skin or nail is minimal, and systemic side effects are not expected with topical formulations. The shampoo may occasionally cause scalp irritation or discolouration of chemically treated hair.
Interactions
Due to negligible systemic absorption from topical formulations, pharmacokinetic drug interactions are not clinically relevant. No interactions with systemic medications have been documented for ciclopirox applied to skin or nails. The nail lacquer contains ethanol; patients with certain nail conditions involving broken skin should be aware of potential stinging. Concurrent use with other topical antifungals in the same area is not routinely recommended without medical guidance.
Special Notes
Ciclopirox nail lacquer is available in Germany both prescription-only and over-the-counter depending on the preparation and indication. The distinction from azole antifungals is clinically relevant when azole resistance or interactions are concerns. Nail cultures or mycological confirmation of onychomycosis before treatment is strongly recommended, as nail discolouration has many non-fungal causes. Patients should be counselled on the long treatment duration and the need for consistent daily application to achieve meaningful nail clearance. Ciclopirox does not interact with warfarin or other anticoagulants, which is an advantage over systemic antifungals like fluconazole.
Related Topics
Frequently Asked Questions
How does ciclopirox differ from azole antifungals?
Azoles inhibit the fungal enzyme lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis. Ciclopirox works by chelating iron and other metal ions essential for multiple enzyme systems. This different mechanism means ciclopirox retains activity against some azole-resistant fungi and does not share the drug interaction profile of systemic azoles affecting cytochrome P450 enzymes.
How long does ciclopirox nail lacquer treatment take?
Treatment for toenail onychomycosis typically requires six months of consistent daily application. Fingernail infections may respond in three to six months. Nail clearance is assessed by gradual growth of healthy nail from the base; complete cure is defined as both mycological eradication and clear nail appearance, which requires time for the full nail to regrow.
Can ciclopirox nail lacquer replace oral antifungals?
For mild to moderate onychomycosis without nail matrix involvement, ciclopirox lacquer is an accepted monotherapy option, particularly when systemic treatment is contraindicated. However, mycological cure rates are lower than with oral terbinafine or itraconazole. In more severe infections or when treatment failure has occurred, systemic therapy is generally preferred.
Sources
- EMA: Ciclopirox nail lacquer Summary of Product Characteristics 2023
- Gupta AK et al: Onychomycosis treatment review. J Eur Acad Dermatol 2022
- AWMF Leitlinie Dermatomykosen 2023